Second Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering

SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced that it has completed its previously announced rights offering to shareholders of record on May 13, 2016. The rights offering was oversubscribed. Second Sight will retain $19.8 million of the subscriptions received, with subscriptions over tha

Full Story →